Study of Vitamin D in Untreated Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

April 13, 2012

Primary Completion Date

November 9, 2019

Study Completion Date

November 9, 2019

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

FOLFOX + bevacizumab

DIETARY_SUPPLEMENT

Vitamin D

Trial Locations (18)

37232

Vanderbilt-Ingram Cancer Center, Nashville

83301

Mountain States Tumor Institute- Twin Falls, Twin Falls

83619

Mountain States Tumor Institute- Fruitland, Fruitland

83642

Mountain States Tumor Institute - Meridian, Meridian

83686

Mountain States Tumor Institute- Nampa, Nampa

83712

Mountain States Tumor Institute at St. Luke's Regional Medical Center, Boise

Unknown

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

Lowell General Hospital, Lowell

Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford

Newton-Wellesley Hospital, Newton

Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital, South Weymouth

New Hampshire Oncology Hematology-P.A., Concord

New Hampshire Oncology Hematology-P.A., Hooksett

New Hampshire Oncology Hematology-P.A., Laconia

Dana-Farber/New Hampshire Oncology-Hematology, Londonderry

02115

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT01516216 - Study of Vitamin D in Untreated Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter